Deficient Proposed Securities Class Action Settlement Against Drug Maker Denied

Mealey's (December 24, 2019, 12:41 PM EST) -- SAN DIEGO — A federal judge in California on Dec. 20 denied a motion for preliminary approval of a securities class action settlement between lead plaintiffs and a biopharmaceutical company and...

To view the full article, register now.